Stocks · Korea
214370
KOSDAQ
Caregen
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER108.27x
PBR10.23x
EPS411 KRW
BPS4,348 KRW
ROE10.89%
Dividend yield0.98%
DPS437 KRW
Payout ratio106.33%
Returns and 52-week range
1W+6.75%
1M+1.03%
3M-35.33%
6M-53.95%
1Y-34.85%
YTD-39.97%
52W high153,800원
52W low38,800원
From 52W high-71.20%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 691억 | 336억 | 272억 | 48.7% |
| 2023 | 792억 | 404억 | 399억 | 51.0% |
| 2024 | 826억 | 342억 | 323억 | 41.5% |
| 2025 | 728억 | 204억 | 201억 | 28.0% |
| Quarterly | ||||
| 2024 4Q | 214억 | 61억 | 51억 | 28.7% |
| 2025 1Q | 213억 | 102억 | 84억 | 47.8% |
| 2025 2Q | 181억 | 74억 | 48억 | 41.1% |
| 2025 3Q | 171억 | 99억 | 102억 | 57.7% |
| 2025 4Q | 163억 | -71억 | -33억 | -43.4% |
| 2026 1Q | 227억 | 102억 | 117억 | 45.0% |
Company
Address: 서울특별시 강남구 역삼로98길 23 (대치동)
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-13분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Recent news
- 2026-10-06[케어젠 딥시크②]美 FDA 넘은 '프로지스테롤' 韓 식약처 도전 4년째 ... 이데일리
- 2026-10-02[케어젠 딥시크①]케어젠 ‘수천억 계약’의 민낯…2400억 계약, 9년간... 이데일리
- 2026-08-11케어젠 "기후변화 대응 항노화 펩타이드 특허 등록" 뉴시스
- 2026-07-03케어젠, 중간배당 결정…보통주 1주당 200원 이데일리
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.